Scientists studying nicotinamide adenine dinucleotide, or NAD+, face an interesting challenge: too much hype around their research. Recently, NAD+ has gained popularity in wellness circles. Celebrities and biohackers are jumping on the bandwagon, claiming it boosts energy, fights aging, and enhances recovery. But is it really that effective?
Christopher Martens, a director at the Delaware Center for Cognitive Aging Research, shares some caution. “Initially, it was exciting. But now, we may be getting ahead of ourselves,” he says. The market for NAD+ products is booming, grounded in scientific findings. However, not all of this enthusiasm is backed by solid evidence.
NAD+ is often touted as a miracle substance, promoting benefits like clearer skin, better sleep, and improved mental clarity. Some wellness clinics describe it as a “fountain of youth,” purportedly revitalizing cells and repairing our DNA.
NAD+ is essential for energy production in our cells. It also plays a role in maintaining healthy DNA. Research shows that NAD+ levels decrease as we age, possibly increasing the risk of age-related diseases, according to Dr. Shalender Bhasin of the Boston Pepper Aging Research Center. He notes that while the concept is appealing, we still lack large-scale human studies to confirm its health benefits.
Most existing studies have been done on animals, showing promise in areas like mitochondrial health and decreased inflammation. Dr. Samuel Klein, from Washington University, cautions, “In rodents, NAD+ seems miraculous. But it’s a different story in humans.”
Our bodies can produce NAD+ from dietary sources, such as vitamin B3 and tryptophan. A historical example is pellagra, a disease from the early 1900s caused by vitamin B3 deficiency, leading to dangerously low NAD+ levels.
Human trials have mostly focused on precursors like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). Some studies indicate benefits for specific groups, like women with prediabetes or Parkinson’s patients. However, not all studies yield encouraging results.
The market for NAD+ products, however, is vast and often misleading. For example, while NAD+ oral supplements claim to help, researchers state the molecule doesn’t get absorbed well in the gut. As a result, they are investigating alternative methods, like precursor pills.
Market prices range widely—pills can cost $30 to $80, while IV infusions might cost hundreds of dollars. Much of this isn’t grounded in rigorous scientific research. Rachel Pojednic from Stanford University argues there’s a need for responsible research in this field and mentions promising early data.
The efficiency of NAD+ infusions is challenged as well. Pojednic notes that while IV infusions of precursors can be more effective, data suggests they may also produce unpleasant side effects like nausea or cramps.
Overall, although initial studies on NAD+ and its precursors appear safe, long-term efficacy and safety in humans remain unclear. As of now, the excitement surrounding NAD+ isn’t entirely supported by solid evidence. Ongoing research may reveal more about its potential, but for now, benefits may be overstated for the general public.
For anyone interested in diving deeper, consider exploring the latest findings on NAD+ from both clinical trials and academic research here.
